For those considering participating in a breast cancer clinical trial, it’s important to understand what happens after the participant is no longer in the study. The study can end for some people before its planned duration is reached, or before the study’s endpoint is determined.

Read more about clinical trials for breast cancer and how you can benefit from them here.

But what exactly happens when a breast cancer clinical trials ends?

There are several reasons for a clinical trial to end. It can be something that the participant decides; participation in a trial is voluntary and it is possible to leave before the study starts, at any time during the trial, or in the follow-up period. On the other hand, the trial can end as a decision from the study researchers themselves.

What happens when a participant leaves the trial before the planned study ends? Find the answer to that question and more, here.

Breast Cancer News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.